TY - JOUR
KW - buprenorphine
KW - carceral treatment
KW - Correctional settings
KW - Jail
KW - medications for addiction treatment (MAT)
KW - Medications for opioid use disorder (MOUD)
KW - opioid agonist therapy (OAT)
KW - Telemedicine
AU - A. M. Belcher
AU - K. Coble
AU - T. O. Cole
AU - C. J. Welsh
AU - A. Whitney
AU - E. Weintraub
A1 - 
AD - Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.
BT - Frontiers in psychiatry
C5 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
DO - 10.3389/fpsyt.2021.703685
JF - Frontiers in psychiatry
LA - eng
M1 - Journal Article
PB - Belcher, Coble, Cole, Welsh, Whitney and Weintraub
PY - 2021
SN - 1664-0640; 1664-0640; 1664-0640
SP - 703685
T1 - Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
T2 - Frontiers in psychiatry
TI - Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder
U1 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 34777036
U3 - 10.3389/fpsyt.2021.703685
VL - 12
VO - 1664-0640; 1664-0640; 1664-0640
Y1 - 2021
Y2 - Oct 28
ER -